Technical Analysis for CTLT - Catalent, Inc.

Grade Last Price % Change Price Change
grade B 50.42 2.67% 1.31
CTLT closed up 2.67 percent on Friday, November 15, 2019, on 64 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CTLT trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
50 DMA Resistance Bearish 2.67%
Fell Below 20 DMA Bearish 2.67%
MACD Bearish Centerline Cross Bearish 2.67%
Bollinger Band Squeeze Range Contraction 2.67%
50 DMA Resistance Bearish 1.76%

Older signals for CTLT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Biotechnology Biopharmaceutical Manufacturing Life Sciences Pharmaceutical Industry Pharmacy Pharmacology Dosage Forms Biologic Products Specialty Drugs In The United States Consumer Health Products Inventory Management Services
Is CTLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 58.38
52 Week Low 29.23
Average Volume 656,220
200-Day Moving Average 48.0949
50-Day Moving Average 49.4964
20-Day Moving Average 49.5575
10-Day Moving Average 49.693
Average True Range 1.1708
ADX 18.04
+DI 18.4233
-DI 20.8632
Chandelier Exit (Long, 3 ATRs ) 47.9171
Chandelier Exit (Short, 3 ATRs ) 51.2324
Upper Bollinger Band 50.7373
Lower Bollinger Band 48.3777
Percent B (%b) 0.87
BandWidth 4.761338
MACD Line 0.056
MACD Signal Line -0.0093
MACD Histogram 0.0653
Fundamentals Value
Market Cap 6.32 Billion
Num Shares 125 Million
EPS 0.87
Price-to-Earnings (P/E) Ratio 57.95
Price-to-Sales 2.57
Price-to-Book 7.36
PEG Ratio 3.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.43
Resistance 3 (R3) 52.21 51.33 52.10
Resistance 2 (R2) 51.33 50.81 51.44 51.98
Resistance 1 (R1) 50.87 50.50 51.10 51.09 51.87
Pivot Point 49.99 49.99 50.10 50.10 49.99
Support 1 (S1) 49.53 49.47 49.76 49.75 48.97
Support 2 (S2) 48.65 49.16 48.76 48.86
Support 3 (S3) 48.19 48.65 48.75
Support 4 (S4) 48.41